Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathological features in bilateral breast cancer.
Baykara M, Ozturk SC, Buyukberber S, Helvaci K, Ozdemir N, Alkis N, Berk V, Koca D, Coskun U, Oksuzoglu B, Uncu D, Arpaci E, Ustaalioglu BO, Demirci U, Kucukoner M, Dogu GG, Alici S, Akman T, Ozkan M, Aslan UY, Durnali AG, Benekli M. Baykara M, et al. Asian Pac J Cancer Prev. 2012;13(9):4571-5. doi: 10.7314/apjcp.2012.13.9.4571. Asian Pac J Cancer Prev. 2012. PMID: 23167382 Free article.
Primary malignant melanoma of the penis: a case report.
Dogu GG, Yaren A, Tuncay L, Senturk N, Zumrutbas AE, Taskoylu BY, Bir F. Dogu GG, et al. Med Oncol. 2012 Jun;29(2):1300-3. doi: 10.1007/s12032-011-9847-6. Epub 2011 Feb 16. Med Oncol. 2012. PMID: 21327740
Primary mesenchymal tumors of the colon: a report of three cases.
Yaren A, Değirmencioğlu S, Callı Demirkan N, Gökçen Demiray A, Taşköylü B, Doğu GG. Yaren A, et al. Among authors: dogu gg. Turk J Gastroenterol. 2014 Jun;25(3):314-8. doi: 10.5152/tjg.2014.4010. Turk J Gastroenterol. 2014. PMID: 25141322 Free article.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Kahraman S, Karakaya S, Kaplan MA, Goksu SS, Ozturk A, Isleyen ZS, Hamdard J, Yildirim S, Dogan T, Isik S, Celebi A, Gulbagci BB, Paksoy N, Dogan M, Turk HM, Bilici A, Tatli AM, Akbas S, Turan N, Hacibekiroglu I, Dogu GG, Aydiner A, Sumbul AT, Akyurek S, Yalciner M, Demirkazik A, Gursoy P, Aykan MB, Sahin E, Karadag İ, Kostek O, Er MM, Artaç M, Duzkopru Y, Aydin D, Isik D, Karakas Y, Kilickap S, Erol C, Demir B, Civelek B, Ergun Y, Akinci MB, Dogan I, Karadurmus N, Yumuk PF, Sendur MAN. Kahraman S, et al. Among authors: dogu gg. Sci Rep. 2024 Mar 9;14(1):5820. doi: 10.1038/s41598-024-56046-w. Sci Rep. 2024. PMID: 38461209 Free PMC article.
Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG).
İçli F, Altundağ K, Akbulut H, Paydaş S, Başaran G, Saip P, Doğu GG, Eralp Y, Uslu R, Sevinç A, Onur H, Mandel NM, Sezgin C, Altınbaş M, Güler N, Işıkdoğan A, Gökmen E, Uygun K, Üstüner Z, Yaren A, Demirkan B, Coşkun U, Ata A, Özkan M, Arican A. İçli F, et al. Among authors: dogu gg. Breast Cancer. 2015 Sep;22(5):480-5. doi: 10.1007/s12282-013-0506-y. Epub 2013 Dec 12. Breast Cancer. 2015. PMID: 24338610
27 results